Tomford W W, Bloem R M, Mankin H J
Department of Orthopedic Surgery, Massachusetts General Hospital, Boston 02114.
Acta Orthop Belg. 1991;57 Suppl 2:98-102.
Over the past eighty years, osteoarticular allografts have provided the possibility of limb-sparing procedures in tumor surgery. Several authors have now reported up to 80 per cent successful use of these types of grafts, and large well-documented series give evidence that limb reconstruction following extensive resection of bone and joints has been possible with their use. In conjunction with their successful applications, studies of the fate of osteoarticular allografts have provided useful information on their associated problems. Infection has been a major complication, affecting up to 12 per cent of recipients and frequently resulting in re-operations and occasionally amputations. Studies have suggested however that almost half of these infections are due to soft-tissue complications rather than to the allografts. Fractures and non-unions, affecting up to 10 per cent of recipients, have proven easier to treat, and few if any patients lose their grafts after fractures. A recent study of retrieved osteoarticular allografts has shown that incorporation of these massive bone segments is slow but progressive, and ultimate incorporation of the grafts can be expected in most patients. The fate of the cartilaginous portion of the grafts has also been evaluated. Our laboratory has suggested that although cryopreservation of the articular portion of the grafts appears feasible in vitro, the fate of transplanted cryopreserved cartilage is dependent on many factors, including accurate sizing and ligamentous reconstruction around the replaced joints. In determining indications for massive osteoarticular allografts, we have found that these grafts are not a panacea for all problems encountered in bone tumor resection, but should be used advisedly for the treatment of specific problems.(ABSTRACT TRUNCATED AT 250 WORDS)
在过去的八十年里,骨关节异体移植为肿瘤手术中的保肢手术提供了可能。现在有几位作者报告称,这些类型的移植成功率高达80%,大量有充分文献记载的系列研究表明,使用它们可以在广泛切除骨骼和关节后进行肢体重建。随着它们的成功应用,对骨关节异体移植命运的研究也为其相关问题提供了有用信息。感染一直是主要并发症,影响高达12%的接受者,经常导致再次手术,偶尔还会导致截肢。然而,研究表明,这些感染中几乎一半是由软组织并发症而非异体移植引起的。骨折和骨不连影响高达10%的接受者,事实证明更容易治疗,骨折后很少有患者失去移植组织。最近一项对回收的骨关节异体移植的研究表明,这些大块骨段的融合缓慢但持续进行,大多数患者最终有望实现移植组织的融合。移植组织软骨部分的命运也得到了评估。我们实验室表明,虽然移植组织关节部分的冷冻保存在体外似乎可行,但冷冻保存软骨移植的命运取决于许多因素,包括精确的尺寸匹配和置换关节周围的韧带重建。在确定大块骨关节异体移植的适应症时,我们发现这些移植并非解决骨肿瘤切除中遇到的所有问题的万灵药,而应谨慎用于治疗特定问题。(摘要截选至250词)